Predictive Models Using Patient-derived Xenograft Mice

1:00 PM ET, 6:00 PM GMT (Convert this time to your time zone)

Patient-derived xenograft (PDX) cancer models show great promise as preclinical models because they recapitulate the heterogeneity of human cancer in a manner that is easily accessible for the research community. The JAX® PDX program was developed in collaboration with renowned cancer hospitals to advance the course of preclinical drug development. In this webinar, you will...

  • Learn how more than 450 PDX models have been established in partnership with a consortium of cancer hospitals and clinical trial teams
  • Appreciate how the diversity of the PDX program represents current patient demographics
  • See how the genetics, pathology, and treatment response of PDX tumors reflect clinical observations
  • Learn how to search for relevant models and find characterization data using the "Mouse Tumor Biology Database"
  • Understand how to obtain PDX models from JAX® In Vivo Pharmacology Services

Please use an institutional email address when registering for this webinar or contact our webinar staff to request an exception.

Subscribe to the JAX Webinar™ mailing list to receive monthly announcements about upcoming complimentary webinars (2-4 each month) on current and cutting edge topics related to using mouse models in biomedical research.

register

Registration is Open

Jan 11

2018